This section lists details of new information added to the MHRA website.
01 Oct 2014 | Company-led drug recall: Phenobarbital 50mg/5ml, Unlicensed Special - Nupharm Laboratories - CLDA (14)A/17
Nupharm Laboratories is recalling certain batches due to the reported crystallisation of the product over time.
01 Oct 2014 | Medical Device Alerts - monthly lists and yearly reviews
A month-by-month list of MDAs that we have issued in 2014, and lists of archived MDAs.
30 Sep 2014 | Medical Device Alert: Neonatal and paediatric support devices: Gel-E Donut and Squishon 2, various part numbers, all batches, manufactured by Philips Healthcare (Children’s Medical Ventures) (MDA/2014/038)
This medical device alert is being issued due to risk of infection, breathing difficulties and allergic reactions caused by mould growth on the devices.
The National Institute for Biological Standards and Control (NIBSC), a centre of the Medicines and Healthcare Products Regulatory Agency (MHRA), has signed an agreement with University College London (UCL) to maximise and further promote scientific collaboration in the field of advanced therapies.
26 Sep 2014 | Good Clinical Practice Symposium 2015
This must-attend annual MHRA event will provide a unique platform for cross-collaboration and discussion between regulators and members of the commercial and non-commercial research community on the latest hot topics and regulatory updates related to the good clinical practice.
26 Sep 2014 | Medical Device Alert: All medical devices (MDA/2014/037)
This medical device alert is being issued due to delays in acting on Field Safety Notices (FSNs).
25 Sep 2014 | Press release: New guidance on reporting suspected adverse drug reactions in children and neonates
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced new simplified guidance for healthcare professionals reporting suspected adverse drug reactions (ADRs) in children to its Yellow Card Scheme.
25 Sep 2014 | Drug Safety Update: September 2014 (Volume 8, Issue 2)
Drug Safety Update is essential reading for all healthcare professionals, bringing you the very latest information and advice to support the safer use of medicines.
23 Sep 2014 | GPC transactions of £500 and above during August 2014
GPC transactions of £500 and above during August 2014.
This consulation seeks comments on proposals to amend the Human Medicines Regulations 2012 to enable Public Health England (PHE) to develop and authorise Patient Group Directions (PGDs).